Off-Label Use of Atypical Antipsychotics: An Update
Clinical Questions Addressed by the Comparative Effectiveness Review (2 of 2)
Key questions addressed by the comparative effectiveness review included: What are the potential adverse effects and/or complications involved with off-label prescribing of atypical antipsychotics? How do they compare within the class and with other drugs used for the conditions? What is the effective dose and time limit for atypical antipsychotics used in off-label indications?
Keywords: antipsychotics | atypical antipsychotics | off-label | second generation | adverse effects
- Maglione M, Ruelaz Maher A, Hu J, et al. Off-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Review No. 43 (Prepared by the Southern California RAND Evidence-based Practice Center under Contract No. HHSA 290-2007-10062-I). Rockville, MD: Agency for Healthcare Research and Quality; September 2011. AHRQ Publication No. 11(12)-EHC087-EF. Available at www.effectivehealthcare.ahrq.gov/offlabelantipsych.cfm.
Your slide tray is being processed.